The online-only Data Supplement is available with this article at http://circres.ahajournals.org/lookup/suppl/Rationale: Carboxylesterase 3/triacylglycerol hydrolase (TGH) has been shown to participate in hepatic very lowdensity lipoprotein (VLDL) assembly. Deficiency of TGH in mice lowers plasma lipids and atherogenic lipoproteins without inducing hepatic steatosis.
T he development of atherosclerosis and coronary heart disease is accelerated in patients with metabolic syndrome characterized by dyslipidemia and insulin resistance. Elevated circulating levels of apolipoprotein B (ApoB)-containing lipoproteins, such as low-density lipoproteins (LDL) and very low-density lipoproteins (VLDL), are recognized independent risk factors for the development of atherosclerosis. 1, 2 Hepatic secretion of VLDL is one of the major determining factors of plasma ApoB concentration. The majority of VLVLtracylglycerol (TG) secreted from hepatocytes is derived from preformed stored TG through a process of lipolysis and reesterification. [3] [4] [5] [6] TG hydrolase (TGH), also termed carboxylesterase 3 (Ces3) or carboxylesterase Ces1d in mice and carboxylesterase 1 (CES1) in humans, has been shown to participate in the provision of substrates for VLDL assembly. [7] [8] [9] [10] [11] [12] [13] Overexpression of TGH in McArdle RH7777 cells augmented TG and ApoB100 secretion in the VLDL density range. 7 Liver-specific overexpression of human TGH in mice resulted in increased ApoB secretion and plasma TG concentration in vivo, 12 whereas inhibition of TGH activity decreased ApoB secretion both in vitro 8 and in vivo. 13 Furthermore, TGH knockout mice presented with reduced plasma lipids and improved insulin sensitivity and glucose homeostasis. 13 The LDL receptor knockout (Ldlr −/− ) mouse is a well-established murine model for the study of atherosclerosis. The LDL receptor plays a major role in the clearance of atherogenic ApoB-containing lipoproteins from the circulation. Due to the prolonged plasma half-life of VLDL and LDL, after a high-fat, high-cholesterol diet, the Ldlr −/− mouse shows severe hyperlipidemia and dramatically elevated circulating atherogenic lipoproteins and consequently develops atherosclerotic lesions. [14] [15] [16] To evaluate whether TGH deficiency would improve dyslipidemia and show protective effect against atherosclerosis development in vivo, we crossed the Tgh −/− mice with Ldlr −/− mice to generate Tgh −/− /Ldlr −/− mice. In the current study, we show that TGH deficiency in Ldlr −/− mice improves plasma lipid and lipoprotein profiles, reduces atherosclerotic lesions, and improves insulin sensitivity.
Methods
An expanded Methods section is available in the Online Data Supplement.
Mice
All animal protocols were approved by the University of Alberta Animal Policy and Welfare Committee. Tgh −/− mice generated previously 13 were back-crossed into C57BL/6J background for 10 generations and were bred with Ldlr −/− mice (C57BL/6J background, Jackson Laboratory, Bar Harbor, ME) to produce Tgh −/− /Ldlr −/− mice. All mice were maintained on a chow diet (LabDiet, PICO laboratory Rodent diet 20). At 10 to 12 weeks of age, age-matched Tgh −/− /Ldlr −/− and Tgh +/+ /Ldlr −/− mice were fed with the high-fat, high-cholesterol diet (TD 88137, Harlan Teklad) containing 21% fat, 0.2% cholesterol by weight, which is usually referred to as Western-type diet (WTD), for 12 weeks. Male mice were used except where indicated.
Lipid and Lipoprotein Analysis
Lipid levels and lipoprotein profiles were determined before and after 12 weeks of WTD. Mice were fasted for 5 hours before blood and tissue collection. Plasma lipoprotein profiles were analyzed by Fast Protein Liquid Chromatography. Plasma and liver lipid concentrations were determined by high-performance liquid chromatography.
Immunoblot Analysis of Plasma ApoB
One microliter of plasma was electrophoresed on SDSen5% polyacrylamide gels. ApoB immunoreactivity was detected by ECL ( Amersham-Pharmacia, Ontario, Canada).
Chylomicron Secretion Rate
Mice fasted for 12 hours received intraperitoneal injection of 1 g/kg body weight of Poloxamer-407. Mice were then gavaged with 150 μL of olive oil containing 10 μCi of 3 Htriolein. Blood was collected at 1 hour, 2 hours, and 4 hours after gavage. Lipids were extracted and separated by thin-layer chromatography (TLC) with the solvent system hexane/isopropyl ether/acetic acid (15:10:1). Lipids were visualized by exposure to iodine, and radioactivity in each lipid class was determined by scintillation counting.
Metabolic Labeling Studies
Primary hepatocytes prepared from the mice were incubated overnight with serum-free DMEM. For incorporation of exogenous fatty acids into lipids, hepatocytes were incubated for 4 hours in 2 mL of DMEM containing 5 μCi 3 Holeic acid (OA) dissolved in 0.4 mmol/L OA/ 0.5% fatty acidenfree bovine serum albumin. Media and cells were harvested, lipids were extracted, resolved by TLC, and radioactivity in various lipid classes was determined. To assess hepatic de novo lipogenesis, primary hepatocytes were incubated for 4 hours in 2 mL of DMEM containing 10 μCi [ 3 H]acetic acid dissolved in 250 mmol/L nonradiolabeled acetic acid. Cells were collected for analysis as described above. Oxidation of [ 3 H]OA was determined in isolated hepatocytes.
In Vivo Insulin Signaling
Animals were fasted for 12 hours; 1 U/kg body weight of human insulin or phosphate-buffered saline was then injected intraperitoneally. Fifteen minutes after injection, liver, skeletal muscle, and white adipose tissue were collected. Phospho-Akt and total Akt levels in the tissues were detected by immunoblotting.
mRNA Expression Analysis
Total RNA was isolated by the Trizol reagent (Life Technologies, Carlsbad, CA). cDNA was synthesized with the Superscript III reverse transcriptase (Invitrogen, Carlsbad, CA). Real-time qPCR was performed with the Platinum SYBR Green qPCR SuperMix-UDG kit (Invitrogen) in the Rotor-Gene 3000 instrument (Montreal Biotech, Quebec, Canada).
Analysis of Aortas
Samples for cross-sectional aortic root analysis were processed as described previously. 17, 18 
Blood Glucose and Insulin Concentrations and Insulin Tolerance Tests
Blood glucose concentrations were determined in 16-hour-fasted mice, using glucose strips (Roche Diagnostics, Vienna, Austria). Serum insulin concentration was analyzed in 16-hour-fasted mice with rat/mouse insulin ELISA kit (Millipore, Billerica, MA). For insulin tolerance tests (ITT), mice were fasted for 6 hours and then intraperitoneally injected with human insulin (0.75 U/kg body weight). Blood glucose concentrations were measured before the insulin injection and 15, 30, 60, and 120 minutes after the injection.
Statistical Analysis
Data are presented as the mean±SEM. Analysis was performed using GraphPad PRISM 4 software. Significant differences between groups were determined by unpaired 2-tailed t test. ITT and fat tolerance test (chylomicron secretion) were analyzed by 2-way ANOVA followed by Bonferroni posttests. P<0.05 was interpreted as significantly different.
Results

TGH Deficiency Improves Atherogenic Lipoprotein Profiles in Ldlr −/− Mice
To investigate whether TGH deficiency would improve dyslipidemia and prevent atherosclerotic lesion formation in Ldlr −/− mice, we generated Tgh −/− /Ldlr −/− mice. WTD-mediated hypertriglyceridemia in Ldlr −/− mice is dramatically decreased in the absence of Tgh expression ( Figure 1A and 1B), In the mice fed chow diet, TGH deficiency did not affect plasma TG concentration in Ldlr −/− male mice ( Figure 1B ) but decreased TG levels were observed in female Tgh −/− /Ldlr −/− mice compared with the Ldlr −/− controls (Online Figure IA ). Similar to male mice, plasma TG concentration was reduced by 50% in WTD fed female Tgh −/− /Ldlr −/− mice, when compared with Ldlr −/− mice (Online Figure IA) . Plasma cholesteryl ester (CE) and free (unesterified) cholesterol levels were higher in both male and female Tgh −/− /Ldlr −/− mice before WTD challenge when compared with Tgh +/+ /Ldlr −/− mice. However, after 12 weeks of WTD feeding, reduction of plasma cholesteryl ester and free cholesterol levels by 30% was observed in male Figure  1B ). This decreased trend was also observed in female Tgh −/− / Ldlr −/− mice but did not reach to the statistical significance (Online Figure IA) . Decreased cholesterol levels in VLDL and LDL fractions and increased high-density lipoprotein (HDL) cholesterol were observed in chow-fed male ( Figure 1C ) and female (Online Figure IB ) Tgh −/− /Ldlr −/− mice. This lipoprotein profile suggested that the increased plasma cholesterol in Tgh −/− /Ldlr −/− mice on chow diet was derived from the HDL cholesterol fraction. Furthermore, after WTD feeding, the lipoprotein profile in Tgh −/− /Ldlr −/− mice was more "atheroprotective," with lower VLDL/ LDL-cholesterol and higher HDL cholesterol than in Tgh +/+ /Ldlr −/− mice ( Figure 1C and Online Figure IB) .
Because there is only 1 ApoB molecule per VLDL particle, 19, 20 plasma ApoB concentrations reflect the number of circulating lipoprotein particles. Chow-fed Tgh −/− /Ldlr −/− mice contained 47% fewer plasma ApoB100 particles than Ldlr −/− mice, whereas plasma ApoB48 concentration was not significantly changed (Figure 2A 
Absence of Exacerbated Hepatic Steatosis in Tgh −/− / Ldlr −/− Mice
We have shown that reducing VLDL secretion in Tgh −/− mice fed chow diet did not result in steatosis. 13 After feeding Tgh −/− / Ldlr −/− mice with WTD for 3 months, the liver weight did not increase with respect to control Ldlr −/− mice (Table) . Hepatic TG and CE contents in the Tgh −/− /Ldlr −/− mice were also similar to the Ldlr −/− mice (Figure 3 ). Furthermore, hepatic free cholesterol levels in Tgh −/− /Ldlr −/− mice were significantly lower than in Ldlr −/− mice (Figure 3 ).
Decreased Hepatic Lipogenesis in Tgh −/− /Ldlr −/− Mice
To evaluate the effect of TGH deficiency on lipid anabolism, hepatocytes were isolated from Tgh −/− /Ldlr −/− and Tgh +/+ / Ldlr −/− mice fed chow and WTD for metabolic lipid labeling studies. Incorporation of [ 3 H]acetic acid into fatty acids, TG, and total cholesterol was significantly decreased in Tgh −/− /Ldlr −/− mice ( Figure 4A ), indicating reduced de novo lipogenesis. The expression of important lipogenic and sterol synthesis genes was either significantly decreased or was trending toward reduction in Tgh −/− /Ldlr −/− mice when Figure 4B ). Sterol-regulatory element binding protein-2 (SREBP2) is a key transcription factor regulating cholesterol biosynthesis including the expression of the rate-limiting enzyme HMG-CoA reductase. The expression of HMG-CoA reductase was found to be lower in Tgh −/− /Ldlr −/− mice, which may have contributed to the reduced hepatic cholesterol levels. Although hepatic gene expression of SREBP1c did not change, fatty acid synthase (FAS), a key enzyme in de novo lipogenesis, showed reduced protein levels in Tgh −/− /Ldlr −/− livers, which might have contributed to the reduced hepatic fatty acid synthesis in these animals. On the other hand, although mRNA expression of SCD1 was significantly reduced in Tgh −/− /Ldlr −/− liver, the protein expression was not different when compared with Tgh +/+ /Ldlr −/− mice (data not shown).
Decreased incorporation of exogenously-supplied radiolabeled OA into TG and CE was observed Tgh −/− /Ldlr −/− hepatocytes ( Figure 4C ), indicating an overall reduction in hepatic neutral lipid synthesis.
Effect of TGH Deficiency on Hepatic Fatty Acid Oxidation
Our previous work showed increased hepatic fatty acid oxidation in chow-fed TGH-deficient mice, 13, 21 which could exert protective effect against hepatic lipid accumulation. In the Ldlr −/− background, TGH deficiency also augmented fatty acid oxidation in hepatocytes isolated from chow-fed mice ( Figure  4D ). However, after 3 months of WTD feeding, there was no difference in fatty acid oxidation between Tgh +/+ /Ldlr −/− and Tgh −/− /Ldlr −/− hepatocytes ( Figure 4D ).
Decreased Atherosclerosis in Tgh −/− /Ldlr −/− Mice Without Changes in Lesion Morphology
To determine whether TGH deficiency has a protective effect on atherosclerosis, we examined the extent of atherosclerotic lesions in the aortic root. In the cross-sectional aortic root analysis, the Oil-Red-O-stained plaque area was significantly reduced by 54% in Tgh −/− /Ldlr −/− mice when compared with Tgh +/+ /Ldlr −/− mice after 12 weeks of the WTD (Figure 5A ). Because some lesion area in Tgh −/− /Ldlr −/− mice was still observed, TGH deficiency significantly decreased but did not completely prevent atherosclerosis development in Ldlr −/− mice. Lesion morphology was analyzed by immunostaining for the smooth muscle cell marker α-actin, macrophage marker MOMA-2, and by trichrome staining for collagen content in aortic plaques. There were no differences observed in the percentage of any of these markers in the lesion area between Tgh +/+ /Ldlr −/− and Tgh −/− /Ldlr −/− mice (Online Figure III) .
Improved Insulin Sensitivity in Tgh −/− /Ldlr −/− Mice
Lower fasting blood glucose concentration was observed in Tgh −/− /Ldlr −/− mice after 3 months of WTD feeding ( Figure  5B ). Fasting insulin concentration in Tgh −/− /Ldlr −/− mice also tended to be lower than in Tgh +/+ /Ldlr −/− mice on WTD ( Figure  5B ). Increased concentration of plasma free fatty acid (FFA) is associated with insulin resistance. 22, 23 Tgh −/− /Ldlr −/− mice on WTD showed reduced circulating fasting FFA when compared with Tgh +/+ /Ldlr −/− mice ( Figure 5B ). Tgh −/− /Ldlr −/− mice also showed markedly improved insulin sensitivity when compared with the control Ldlr −/− mice ( Figure 5C ). Phosphorylation of Akt in response to insulin showed increased trend in the liver, muscle, and white adipose tissue of Tgh −/− /Ldlr −/− mice, suggesting improved insulin signaling ( Figure 5D ). However, no difference was observed in oral glucose tolerance test between Tgh +/+ /Ldlr −/− and Tgh −/− /Ldlr −/− mice after 3 months of WTD (Online Figure IV) .
Both Tgh +/+ /Ldlr −/− and Tgh −/− /Ldlr −/− mice presented with WTD-induced increase in adipose tissue mass. Tgh −/− /Ldlr −/− mice did not show any difference in white adipose tissue and brown adipose tissue weights (Table) compared with Tgh +/+ / Ldlr −/− , even though plasma lipid levels and atherosclerosis were decreased.
Discussion
In the absence of sufficient TG supply for VLDL assembly, ApoB is targeted for degradation instead of secretion. 24, 25 TGH was demonstrated to play an important role in lipidation of ApoB100. Therefore, we hypothesized that ablation of Tgh expression in LDLR-deficient mice might improve dyslipidemia and afford protection against development of atherosclerosis. Our study has shown that TGH deficiency results in decreased concentration of cholesterol in the VLDL/LDL fractions and in increased plasma HDL cholesterol, reflecting an atheroprotective plasma lipid profile. An inverse relationship between plasma HDL cholesterol and cardiovascular disease, including atherosclerosis, has been demonstrated. [26] [27] [28] [29] HDL may exert antiatherogenic effects through its role in the reverse cholesterol transport 30 and by its antioxidative and anti-inflammatory properties. 31-33 HDL particles in Tgh −/− /Ldlr −/− mice appear to be slightly larger, based on their elution profile from the gel filtration column, suggesting increased CE content. The elevated HDL cholesterol combined with lower ApoB-lipoprotein concentrations in Tgh −/− /Ldlr −/− mice contributed to the reduced atherosclerotic lesions in these mice. Thus, these data provide evidence that attenuation of TGH activity improves diet-induced dyslipidemia and associated atherosclerosis.
One major concern in inhibiting VLDL secretion is that such an approach might lead to severe hepatic lipid accumulation. For instance, inhibition of microsomal triglyceride transfer protein activity, an activity required for basal lipidation and folding of ApoB, decreased VLDL secretion and plasma lipid concentration at the expense of hepatic steatosis. [34] [35] [36] Importantly, ablation of TGH in Ldlr −/− mice did not provoke further hepatic lipid accumulation after WTD challenge. Moreover, hepatic free (unesterified) cholesterol concentration in Tgh −/− /Ldlr −/− mice was significantly decreased compared with Tgh +/+ /Ldlr −/− mice. Free cholesterol is known to be highly cytotoxic and has been implicated in liver injury and pathogenesis of nonalcoholic fatty liver disease. [37] [38] [39] Because the hepatic expression levels of CYP7A1, the key enzyme of bile acid synthesis, ABCG5, an ATP-binding cassette transporter that promotes biliary sterol excretion, and ABCA1, an ABC transporter that plays an important role in reserve cholesterol transport, were similar between Tgh −/− /Ldlr −/− and Tgh +/+ /Ldlr −/− mice (data not shown), the lower hepatic free cholesterol levels in Tgh −/− /Ldlr −/− mice probably were not due to increased cholesterol excretion or decreased cholesterol uptake. Rather, hepatocytes isolated from Tgh −/− /Ldlr −/− mice showed decreased cholesterol synthesis, which may be due to the downregulated expression of SREBP2 and HMG-CoA reductase.
Insulin resistance and type 2 diabetes are generally accompanied by dyslipidemia, and this condition is highly associated with cardiovascular disease. 40 Tgh −/− mice present with improved glucose tolerance and insulin sensitivity. 13 Ablation of Tgh expression in the Ldlr −/− background resulted in lower blood glucose levels and improved insulin sensitivity, which benefits energy homeostasis and exerts a protective effect against the development of atherosclerosis. Insulin resistance has been demonstrated to affect the activities of lipases involved in HDL metabolism in vivo, thereby decreasing circulating HDL cholesterol. [41] [42] [43] The improved insulin sensitivity in Tgh −/− /Ldlr −/− mice may therefore also contribute to the elevated HDL cholesterol levels observed in these mice.
It has been demonstrated that FAS expression is upregulated in high-fat die ten induced hepatic steatosis and insulin resistance. 44, 45 In Tgh −/− /Ldlr −/− mice fed with WTD for 3 months, hepatic FAS expression was significantly decreased when compared with Tgh +/+ /Ldlr −/− mice, which may have contributed to decreased fatty acid synthesis in TGH deficient Ldlr −/− mice. Reduced FAS expression in Tgh −/− /Ldlr −/− mice is probably the consequence of decreased blood insulin concentration and improved insulin sensitivity 46 in these mice. Attenuated FAS expression could lead to augmented fatty acid oxidation in the liver due to reduction of malonyl-CoA and subsequent removal of inhibition of fatty acid import into mitochondria by CPT-1. However, fatty acid oxidation was not affected in Tgh −/− /Ldlr −/− hepatocytes after WTD, suggesting that reduction of lipid synthesis and delivery of lipids to the liver from intestinal lipoproteins might be the main mechanism responsible for the absence of further steatosis in Tgh −/− / Ldlr −/− mice despite decreased VLDL secretion.
In conclusion, we showed that the decreased ApoB secretion caused by TGH deficiency reduced the amount of circulating atherogenic lipoproteins and lipid levels in Ldlr −/− background after WTD feeding. The atheroprotective lipid profile in Tgh −/− /Ldlr −/− mice is presumably the major reason for the observed reduction of atherosclerotic lesions induced by WTD. Importantly, TGH deficiency did not induce further liver steatosis in Ldlr −/− mice. The decreased blood glucose concentrations and increased insulin sensitivity in Tgh −/− / Ldlr −/− mice also implies improvements in metabolic control.
